Advances in antiplatelet technologies to improve cardiovascular disease morbidity and mortality: A review of ticagrelor
Clinical Pharmacology: Advances and Applications, October 31, 2013
Free full text
Favourable 5-year postdischarge survival of comatose patients resuscitated from out-of-hospital cardiac arrest, managed with immediate coronary angiogram on admission
European Heart Journal: Acute Cardiovascular Care, February 27, 2014
Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non–ST-segment–elevation acute coronary syndromes or stable ischemic heart disease
Circulation: Cardiovascular Interventions, June 20, 2014
Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention validation of the logistic clinical syntax (synergy between percutaneous coronary interventions with taxus and cardiac surgery) score
JACC Cardiovascular Interventions, July 30, 2013
Incidence and outcome of high on-treatment platelet reactivity in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention (from the vip [verifynow and inhibition of platelet reactivity] study)
The American Journal of Cardiology, September 6, 2013
Question: In ACS patients, which factor is NOT independently associated with an increased risk incidence of pre-hospital cardiac arrest?
Question: What is the approximate in-hospital mortality for STEMI patients who present with cardiac arrest?
Question: True or false: In patients with STEMI, an investigational trial of IV glucose-insulin-potassium treatment significantly reduced the risk of composites cardiac arrest and/or mortality with and without HF hospitalization within 1 year.